| Pharmaceutical Trading | Trading of APIs, pharmaceutical intermediates, and raw materials used in drug manufacturing. | Strong supplier relationships, wide product portfolio, export capabilities, and regulatory compliance presence. | B2B model serving pharmaceutical manufacturers domestically and internationally. | Specialty pharmaceutical intermediates and advanced API trading segments. | 405 | 100 | Revenue from sales of pharmaceutical raw materials to pharma companies and intermediates suppliers. | Direct sales based on bulk trading contracts and market-driven pricing. | Increasing pharma production demand, expansion into regulated markets, and acquisition of contract manufacturing orders. | |
